Literature DB >> 20871615

Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.

Rémi Buisson1, Anne-Marie Dion-Côté, Yan Coulombe, Hélène Launay, Hong Cai, Alicja Z Stasiak, Andrzej Stasiak, Bing Xia, Jean-Yves Masson.   

Abstract

Inherited mutations in human PALB2 are associated with a predisposition to breast and pancreatic cancers. PALB2's tumor-suppressing effect is thought to be based on its ability to facilitate BRCA2's function in homologous recombination. However, the biochemical properties of PALB2 are unknown. Here we show that human PALB2 binds DNA, preferentially D-loop structures, and directly interacts with the RAD51 recombinase to stimulate strand invasion, a vital step of homologous recombination. This stimulation occurs through reinforcing biochemical mechanisms, as PALB2 alleviates inhibition by RPA and stabilizes the RAD51 filament. Moreover, PALB2 can function synergistically with a BRCA2 chimera (termed piccolo, or piBRCA2) to further promote strand invasion. Finally, we show that PALB2-deficient cells are sensitive to PARP inhibitors. Our studies provide the first biochemical insights into PALB2's function with piBRCA2 as a mediator of homologous recombination in DNA double-strand break repair.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871615      PMCID: PMC4094107          DOI: 10.1038/nsmb.1915

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  46 in total

1.  Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

Authors:  A A Davies; J Y Masson; M J McIlwraith; A Z Stasiak; A Stasiak; A R Venkitaraman; S C West
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

2.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

3.  The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction.

Authors:  Haijuan Yang; Qiubai Li; Jie Fan; William K Holloman; Nikola P Pavletich
Journal:  Nature       Date:  2005-02-10       Impact factor: 49.962

4.  CeBRC-2 stimulates D-loop formation by RAD-51 and promotes DNA single-strand annealing.

Authors:  Mark I R Petalcorin; Jane Sandall; Dale B Wigley; Simon J Boulton
Journal:  J Mol Biol       Date:  2006-06-27       Impact factor: 5.469

5.  Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.

Authors:  Eloïse Dray; Julia Etchin; Claudia Wiese; Dorina Saro; Gareth J Williams; Michal Hammel; Xiong Yu; Vitold E Galkin; Dongqing Liu; Miaw-Sheue Tsai; Shirley M-H Sy; David Schild; Edward Egelman; Junjie Chen; Patrick Sung
Journal:  Nat Struct Mol Biol       Date:  2010-09-26       Impact factor: 15.369

6.  Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair.

Authors:  Amitabh V Nimonkar; A Zeynep Ozsoy; Jochen Genschel; Paul Modrich; Stephen C Kowalczykowski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-29       Impact factor: 11.205

7.  CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.

Authors:  Fumiko Esashi; Nicole Christ; Julian Gannon; Yilun Liu; Tim Hunt; Maria Jasin; Stephen C West
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

8.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  Analysis of PALB2/FANCN-associated breast cancer families.

Authors:  Marc Tischkowitz; Bing Xia; Nelly Sabbaghian; Jorge S Reis-Filho; Nancy Hamel; Guilan Li; Erik H van Beers; Lili Li; Tayma Khalil; Louise A Quenneville; Atilla Omeroglu; Aletta Poll; Pierre Lepage; Nora Wong; Petra M Nederlof; Alan Ashworth; Patricia N Tonin; Steven A Narod; David M Livingston; William D Foulkes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

Review 10.  The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability.

Authors:  K Gudmundsdottir; A Ashworth
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

View more
  145 in total

1.  ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair.

Authors:  Jean-Yves Bleuyard; Rémi Buisson; Jean-Yves Masson; Fumiko Esashi
Journal:  EMBO Rep       Date:  2012-02-01       Impact factor: 8.807

2.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

3.  Coupling of Homologous Recombination and the Checkpoint by ATR.

Authors:  Rémi Buisson; Joshi Niraj; Amélie Rodrigue; Chu Kwen Ho; Johannes Kreuzer; Tzeh Keong Foo; Emilie J-L Hardy; Graham Dellaire; Wilhelm Haas; Bing Xia; Jean-Yves Masson; Lee Zou
Journal:  Mol Cell       Date:  2017-01-12       Impact factor: 17.970

Review 4.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

5.  GST-His purification: a two-step affinity purification protocol yielding full-length purified proteins.

Authors:  Ranjan Maity; Joris Pauty; Jana Krietsch; Rémi Buisson; Marie-Michelle Genois; Jean-Yves Masson
Journal:  J Vis Exp       Date:  2013-10-29       Impact factor: 1.355

6.  Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.

Authors:  Soma Ghosh; Surojit Sur; Sashidhar R Yerram; Carlo Rago; Anil K Bhunia; M Zulfiquer Hossain; Bogdan C Paun; Yunzhao R Ren; Christine A Iacobuzio-Donahue; Nilofer A Azad; Scott E Kern
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

7.  Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.

Authors:  Yanying Huo; Hong Cai; Irina Teplova; Christian Bowman-Colin; Guanghua Chen; Sandy Price; Nicola Barnard; Shridar Ganesan; Vassiliki Karantza; Eileen White; Bing Xia
Journal:  Cancer Discov       Date:  2013-05-06       Impact factor: 39.397

8.  Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.

Authors:  Christian Bowman-Colin; Bing Xia; Samuel Bunting; Christiaan Klijn; Rinske Drost; Peter Bouwman; Laura Fineman; Xixi Chen; Aedin C Culhane; Hong Cai; Scott J Rodig; Roderick T Bronson; Jos Jonkers; Andre Nussenzweig; Chryssa Kanellopoulou; David M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-08       Impact factor: 11.205

9.  MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.

Authors:  Fan Zhang; Gregory Bick; Jung-Young Park; Paul R Andreassen
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

10.  Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.

Authors:  Ciyu Yang; Angela G Arnold; Magan Trottier; Yukio Sonoda; Nadeem R Abu-Rustum; Oliver Zivanovic; Mark E Robson; Zsofia K Stadler; Michael F Walsh; David M Hyman; Kenneth Offit; Liying Zhang
Journal:  Breast Cancer Res Treat       Date:  2016-10-18       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.